Shinichi Makita
Chuo, 1040045, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Management of ICANS in Patient Treated with Anti-CD19 CAR T-Cell Therapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 04, 2026
Effectiveness of anti-CD19 CAR T-cell therapy for high-grade B-cell lymphoma in Japan: a single-institution analysis.
Journal: International journal of clinical oncology
Published: May 02, 2026
Association between CD79B expression and polatuzumab vedotin efficacy, and therapy-induced changes in CD79B expression in diffuse large B-cell lymphoma.
Journal: Virchows Archiv : an international journal of pathology
Published: March 27, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.
Journal: Blood advances
Published: February 04, 2026
Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma.
Journal: British journal of haematology
Published: February 03, 2026
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel.
Journal: International journal of hematology
Published: January 19, 2026
Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Journal: International journal of clinical oncology
Published: January 15, 2026
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphoma.
Journal: International journal of clinical oncology
Published: January 09, 2026
Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma.
Journal: International journal of clinical oncology
Published: October 29, 2025
Consideration of the natural history of BCL2-positive follicular lymphoma: based on tumor site, histological grade, and histological transformation rate.
Journal: Human pathology
Published: October 26, 2025
Diffuse large B-cell lymphoma: current treatment strategy and future outlook
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Last Updated: 09/26/2026